JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
UFP Technologies
UFPT
$2.51B
| $841K | ﹤0.01% |
16,952
+7,017
| +71% | +$306K |
|
3802
Merit Medical Systems
MMSI
$5.42B
| $839K | ﹤0.01% |
26,874
-17,386
| -39% | -$498K |
|
3803
Axsome Therapeutics
AXSM
$11.4B
| $837K | ﹤0.01% |
8,094
-37,397
| -82% | -$1.51M |
|
3804
PC Connection
CNXN
$2.04B
| $836K | ﹤0.01% |
16,848
-1,942
| -10% | -$90.1K |
|
|
STEL
3805
DELISTED
Stellar Bancorp
STEL
| $836K | ﹤0.01% |
26,859
+20,958
| +355% | +$615K |
|
3806
ATN International
ATNI
$490M
| $835K | ﹤0.01% |
15,074
-18,411
| -55% | -$1.05M |
|
3807
Angi Inc
ANGI
$188M
| $834K | ﹤0.01% |
9,852
+9,248
| +1,531% | +$691K |
|
|
HTT
3808
High Templar Tech Ltd
HTT
$390M
| $832K | ﹤0.01% |
176,686
-623,659
| -78% | -$3.67M |
|
3809
Replimune Group
REPL
$1.45B
| $832K | ﹤0.01% |
57,965
+54,162
| +1,424% | +$780K |
|
3810
Nabors Industries
NBR
$1.34B
| $829K | ﹤0.01% |
5,758
-107,957
| -95% | -$11.4M |
|
|
ABB
3811
DELISTED
ABB Ltd
ABB
| $829K | ﹤0.01% |
34,384
-10,142
| -23% | -$217K |
|
|
CIR
3812
DELISTED
CIRCOR International, Inc
CIR
| $828K | ﹤0.01% |
17,899
+5,303
| +42% | +$219K |
|
|
NAV
3813
DELISTED
Navistar International
NAV
| $828K | ﹤0.01% |
28,604
-40,754
| -59% | -$1.25M |
|
|
VSTO
3814
DELISTED
Vista Outdoor Inc.
VSTO
| $827K | ﹤0.01% |
110,624
-99,147
| -47% | -$744K |
|
|
MEET
3815
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $824K | ﹤0.01% |
164,442
+103,360
| +169% | +$486K |
|
3816
Kura Oncology
KURA
$922M
| $823K | ﹤0.01% |
59,878
+22,577
| +61% | +$335K |
|
3817
ROBO Global Robotics & Automation Index ETF
ROBO
$2.12B
| $820K | ﹤0.01% |
19,523
-3,246
| -14% | -$131K |
|
3818
Vail Resorts
MTN
$5.23B
| $818K | ﹤0.01% |
3,413
-27,572
| -89% | -$6.52M |
|
3819
PUT
PAR Technology
PAR
$743M
| $818K | ﹤0.01% |
+26,600
| New | +$728K |
|
3820
ADT
ADT
$5.35B
| $813K | ﹤0.01% |
102,539
-127,611
| -55% | -$1.01M |
|
3821
Phreesia
PHR
$758M
| $812K | ﹤0.01% |
30,469
+19,695
| +183% | +$544K |
|
3822
Shake Shack
SHAK
$2.93B
| $812K | ﹤0.01% |
13,628
-16,769
| -55% | -$1.21M |
|
3823
KALA BIO
KALA
$17M
| $811K | ﹤0.01% |
88
-17
| -16% | -$164K |
|
|
XLNX
3824
CALL
DELISTED
Xilinx Inc
XLNX
| $811K | ﹤0.01% |
8,300
| – | – |
|
|
MDR
3825
DELISTED
McDermott International
MDR
| $811K | ﹤0.01% |
1,199,261
+1,132,342
| +1,692% | +$1.45M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.